One embodiment provides administering the disclosed PSG modulators to a subject, such as a mammal, in an effective amount to modulate PSG expression, in particular to modulate PSG expression in vascular smooth muscle cells, endothelial cells, or a combination thereof to treat a vascular pathology such as atheroscler